TLQP 21
£125.00 1mg
Please note: this product can only be supplied to registered research and development facilities, and may be used for in vitro research use only, not for administration to humans or animals.
VGF derived peptide.
TLQP 21 is a peptide named for its four N-terminal amino acids and length, which is derived from the 617 amino acid VGF precursor by proteolytic processing. The target for TLQP 21 is the C3a receptor-1 (C3aR1), a G-protein coupled receptor that is activated by the complement activation product C3a, itself considered a component of innate immunity. TLQP 21 plays a role in the central and peripheral nervous system to regulate feeding, reproductive and circadian behaviours and has a role in neuropathic pain and peripheral adiposity.
Please contact us for availability.
Additional information
Three Letter Sequence | H-Thr-Leu-Gln-Pro-Pro-Ala-Ser-Ser-Arg-Arg-Arg-His-Phe-His-His-Ala-Leu-Pro-Pro-Ala-Arg-OH |
---|---|
Molecular Weight | 2432.77 |
Molecular Formula | C107H170N40O26 |
Sequence | TLQPPASSRRRHFHHALPPAR |
Solubility | Soluble to 1 mg/ml in water |
Appearance | Freeze dried solid |
Storage | Store dry, frozen and in the dark |
Purity | >95% by HPLC |
Searchable Words | TLQP 21, RT-020, RT020, 869988-94-3, TLQPPASSRRRHFHHALPPAR, TLQP-21, TLQP21 |